Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Release
Share
Press Release
Jan 23, 2020
| Rachel Schwartz
AAM Statement on Avalere Analysis of Generic Substitution
Press Release
Jan 16, 2020
| Rachel Schwartz
AAM Statement on Senate Passage of USMCA Agreement
Press Release
Jan 8, 2020
| Rachel Schwartz
AAM Statement on "The Unintended Economics of the BLOCKING Act" Report
Press Release
Jan 7, 2020
| Rachel Schwartz
Katherine Michelle Raab Joins AAM as Vice President, Federal Government Affairs
Press Release
Dec 19, 2019
| Rachel Schwartz
USMCA Sets a New Standard for Lowering Drug Prices and Expanding Access to Medicines
Press Release
Dec 17, 2019
| Rachel Schwartz
AAM Applauds House Passage of the CREATES Act
Press Release
Dec 13, 2019
| Rachel Schwartz
AAM Statement on HR 3
Press Release
Dec 10, 2019
| Rachel Schwartz
USMCA Trade Agreement: A Victory for America’s Patients
Press Release
Dec 9, 2019
| Rachel Schwartz
AAM Opposes the Lower Health Care Costs Act
Press Release
Nov 1, 2019
| Rachel Schwartz
AAM Statement on Nomination of Dr. Stephen Hahn to FDA
Press Release
Oct 29, 2019
| Rachel Schwartz
AAM Statement on 2019 FDA Drug Shortages Task Force Report
Press Release
Oct 23, 2019
| Rachel Schwartz
AAM Launches #DoesntAddUp Ad Campaign to Bring Down Prescription Drug Costs for Patients in the U.S.
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action